MBX Biosciences, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001172661-25-003266 | Aug 14, 2025 | — |
| UPLOAD | — | 0000000000-25-008532 | Aug 13, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000299 | Aug 12, 2025 | — |
| DRS | — | 0000950123-25-007329 | Aug 8, 2025 | — |
| 8-K | 8-K | 0000950170-25-104602 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104619 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-086546 | Jun 16, 2025 | — |
| 8-K | 8-K | 0000950170-25-083447 | Jun 9, 2025 | — |
| 4 | 4 | 0000950170-25-082713 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-082703 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-082702 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-082701 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-082699 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-082698 | Jun 6, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0000950170-25-082697 | Jun 6, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-082773 | Jun 6, 2025 | Jun 5, 2025 |
| 10-Q | 10-Q | 0000950170-25-068602 | May 12, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-068599 | May 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000189 | May 12, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-056980 | Apr 23, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-056978 | Apr 23, 2025 | Apr 22, 2025 |
| ARS | ARS | 0000950170-25-056981 | Apr 23, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-052685 | Apr 10, 2025 | Apr 8, 2025 |
| 4 | 4 | 0000950170-25-052313 | Apr 9, 2025 | Apr 7, 2025 |
| 8-K | 8-K | 0000950170-25-051371 | Apr 7, 2025 | — |
| 3 | 3 | 0000950170-25-051379 | Apr 7, 2025 | — |
| 10-K | 10-K | 0000950170-25-039838 | Mar 17, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-039837 | Mar 17, 2025 | — |
| S-8 | S-8 | 0000950170-25-039843 | Mar 17, 2025 | — |
| 4 | — | 0000947871-25-000199 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | — | 0000947871-25-000200 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | 4 | 0000950170-25-014497 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-014494 | Feb 5, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-014499 | Feb 5, 2025 | Feb 3, 2025 |
| 8-K | 8-K | 0000950170-25-002555 | Jan 7, 2025 | — |
| SC 13G | SEC SCHEDULE 13G | 0000902219-24-000474 | Nov 8, 2024 | — |
| 8-K | 8-K | 0000950170-24-122824 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-122840 | Nov 7, 2024 | Sep 30, 2024 |
| SC 13G | SC 13G | 0001193125-24-249976 | Nov 1, 2024 | — |
| SC 13G | — | 0001172661-24-004091 | Sep 23, 2024 | — |
| SC 13D | SC 13D | 0001193125-24-223402 | Sep 23, 2024 | — |
| SC 13D | SCHEDULE 13D | 0000947871-24-000767 | Sep 23, 2024 | — |
| SC 13D | SC 13D | 0001104659-24-102144 | Sep 23, 2024 | — |
| SC 13D | NEW ENTERPRISE ASSOCIATES 17, L.P. -- MBX BIOSCIENCES, INC. 13D | 0001072613-24-000721 | Sep 23, 2024 | — |
| SC 13G | SEC SCHEDULE 13G | 0001903360-24-000002 | Sep 20, 2024 | — |
| 4 | 4 | 0000950170-24-107552 | Sep 17, 2024 | Sep 16, 2024 |
| 4 | 4 | 0000950170-24-107549 | Sep 17, 2024 | Sep 16, 2024 |
| 4 | 4 | 0000950170-24-107547 | Sep 17, 2024 | Sep 16, 2024 |
| 4 | 4 | 0000950170-24-107544 | Sep 17, 2024 | Sep 16, 2024 |
| 4 | 4 | 0000950170-24-107542 | Sep 17, 2024 | Sep 16, 2024 |